KLRK1 and neoplasm: NKG2D-CAR-NK cells, through the incorporation of NKG2D transmembrane domains, specifically mediate NK cell signal transduction, significantly enhancing cytotoxic effects against diverse tumor cell lines, and maintaining robust antitumor activity even within hypoxic TME [56].